Buchumschlag

Review article: advances in the diagnosis and management of anorectal motility disorders

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Dariush Shahsavari, Satish S. C. Rao
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Alimentary Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Review article: Recent advances in ascites and acute kidney injury management in cirrhosis
von: Danielle Adebayo, et al.
Veröffentlicht: (2024)

Review article: Oesophageal disorders in chronic liver disease
von: Francisco Idalsoaga, et al.
Veröffentlicht: (2024)

Review article: Diagnosis and management of laryngopharyngeal reflux
von: Amanda J. Krause, et al.
Veröffentlicht: (2024)

Review article: Evidence‐based dietary management of inflammatory bowel disease
von: Peter R. Gibson, et al.
Veröffentlicht: (2024)

Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
von: Camille Lupianez‐Merly, et al.
Veröffentlicht: (2024)

Review article: The epidemiology and management of Clostridioides difficile infection—A clinical update
von: Lindsay M. Clarke, et al.
Veröffentlicht: (2024)

Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors
von: Matthew J. Townsend, et al.
Veröffentlicht: (2024)

Review article: Prevention of inflammatory bowel disease—The path forward
von: Sérgio Bronze, et al.
Veröffentlicht: (2024)

Review article: Recommendations for detection, assessment and management of suspected drug‐induced liver injury during clinical trials in oncology patients
von: Anna Fettiplace, et al.
Veröffentlicht: (2024)

Review article: Evaluation and care of the critically ill patient with cirrhosis
von: Iva Kosuta, et al.
Veröffentlicht: (2024)

Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implications
von: Christy Riggott, et al.
Veröffentlicht: (2024)

Review article: Novel therapies in inflammatory bowel disease – An update for clinicians
von: Nurulamin M. Noor, et al.
Veröffentlicht: (2024)

Review article: Telecare in gastroenterology—Within the COVID‐19 pandemic and beyond
von: Fatima Hakak, et al.
Veröffentlicht: (2024)

Review article: Current status and future directions of ingestible electronic devices in gastroenterology
von: Phoebe A. Thwaites, et al.
Veröffentlicht: (2024)

Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission
von: Arta Aliu, et al.
Veröffentlicht: (2024)

Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel disease
von: Thanaboon Chaemsupaphan, et al.
Veröffentlicht: (2024)

Review article: Faecal biomarkers for assessing small intestinal damage in coeliac disease and environmental enteropathy
von: Laura Kivelä, et al.
Veröffentlicht: (2024)

Review article: Seeing Is Believing–The Eosinophilic Oesophagitis Endoscopic Reference Score Can Serve as a Valuable Clinical Trial Endpoint in Eosinophilic Oesophagitis
von: Ikuo Hirano, et al.
Veröffentlicht: (2025)

Editorial: How often can we get the right diagnosis after bone marrow transplant in patients with abnormal liver function tests?
von: C. Gaume, et al.
Veröffentlicht: (2024)

Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease
von: Tsz Hong Yiu, et al.
Veröffentlicht: (2024)

Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease
von: Nina Dominik, et al.
Veröffentlicht: (2024)

Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD
von: Maria Ling Lundström, et al.
Veröffentlicht: (2024)

Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease
von: Jannis Kountouras, et al.
Veröffentlicht: (2024)

Editorial: ARFI‐based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity
von: Davide Roccarina, et al.
Veröffentlicht: (2024)

Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma
von: Enrico N. De Toni, et al.
Veröffentlicht: (2024)

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply
von: Stuart McPherson, et al.
Veröffentlicht: (2024)

The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes
von: Lana Bridi, et al.
Veröffentlicht: (2024)

Letter: The multifaceted role of Escherichia coli in influencing disorders of industrial populations
von: Maria Rosa Ingrosso, et al.
Veröffentlicht: (2024)

Functional Constipation: Pathophysiology, evaluation, and management
von: Alexandra Kilgore, et al.
Veröffentlicht: (2024)

Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2–F3 fibrosis
von: Yusuf Yilmaz
Veröffentlicht: (2024)

Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection
von: Lisa Sandmann, et al.
Veröffentlicht: (2024)

The contribution of dietary advanced glycation end‐products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study
von: Fangyuan Jiang, et al.
Veröffentlicht: (2024)

Development of hepatic fibrosis in common variable immunodeficiency‐related porto‐sinusoidal vascular disorder
von: Julian Hercun, et al.
Veröffentlicht: (2024)

Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2‐F3 fibrosis. Authors' reply
von: Stuart McPherson, et al.
Veröffentlicht: (2024)

Editorial: The future of managing drug induced liver injury
von: Amanda Nicoll
Veröffentlicht: (2024)

Psychiatric disorders in patients with hepatocellular carcinoma: A large US cohort of commercially insured individuals
von: Mausam J. Patel, et al.
Veröffentlicht: (2024)

Letter: Potential impact ofHelicobacter pyloriinfection on oesophageal disorders in chronic liver disease—Authors' reply
von: Francisco Idalsoaga, et al.
Veröffentlicht: (2024)

UK guideline on the transition and management of childhood liver diseases in adulthood
von: Deepak Joshi, et al.
Veröffentlicht: (2024)

Duke Activity Status Index and Liver Frailty Index predict mortality in ambulatory patients with advanced chronic liver disease: A prospective, observational study
von: Felicity R. Williams, et al.
Veröffentlicht: (2024)

Review Article: Surrogate Endpoints to Assess Treatment Efficacy in Disorders of Gut–Brain Interaction of Lower Gastrointestinal Tract
von: Michael Camilleri, et al.
Veröffentlicht: (2025)